Safety in Lactation: Drugs for movement disorders

10 November 2018Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance.  Drugs for dystonias and other involuntary…

Hypersalivation – what are the treatment alternatives to glycopyrronium and hyoscine?

1 August 2018This Medicines Q&A outlines possible alternatives to hyoscine hydrobromide and glycopyrronium in the treatment of non drug-induced hypersalivation, e.g. botulinum toxin, amitriptyline, atropine (eye drops…
Search Articles

Medicine Compliance Aid Stability

NootropilUCB Pharma Ltd

UCB Pharma Ltd
Tablets f/c 800mg, 1200mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special precautions for storage
15 October 2015

Lactation Safety Information

Adjunct for cortical myoclonus
No published evidence of safety
Monitor infant for adverse effects associated with adult use
8 November 2018